Newbridge Financial Services Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.73K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.14K | Sell |
|
|||||
|
2024
Q3 | $9.4K | Sell |
|
|||||
|
2024
Q2 | $41.9K | Hold |
|
|||||
|
2024
Q1 | $52.9K | Sell |
|
|||||
|
2023
Q4 | $67.4K | Buy |
|
|||||
|
2023
Q3 | $32.6K | Buy |
|
|||||
|
2023
Q2 | $29.1K | Hold |
|
|||||
|
2023
Q1 | $23.4K | Hold |
|
|||||
|
2022
Q4 | $21.1K | Hold |
|
|||||
|
2022
Q3 | $34K | Buy |
|
|||||
|
2022
Q2 | $31K | Sell |
|
|||||
|
2022
Q1 | $54K | Buy |
|
|||||
|
2021
Q4 | $43K | Buy |
|
|||||
|
2021
Q3 | $32K | Buy |
|
|||||
|
2021
Q2 | $38K | Hold |
|
|||||
|
2021
Q1 | $29K | Sell |
|
|||||
|
2020
Q4 | $212K | Sell |
|
|||||
|
2020
Q3 | $138K | Buy |
|